1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and naloxone

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with naloxone in 2 studies

Compound Research Comparison

Studies (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)	Trials (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)	Recent Studies (post-2010) (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)	Studies (naloxone)	Trials (naloxone)	Recent Studies (post-2010) (naloxone)
26	0	5	20,134	1,257	3,321

Protein Interaction Comparison

Protein	Taxonomy	naloxone (IC50)
Cytochrome P450 2D6	Homo sapiens (human)	2
Delta-type opioid receptor	Mus musculus (house mouse)	0.043
Delta-type opioid receptor	Rattus norvegicus (Norway rat)	0.0219
Mu-type opioid receptor	Rattus norvegicus (Norway rat)	0.0019
Kappa-type opioid receptor	Rattus norvegicus (Norway rat)	0.0019
Mu-type opioid receptor	Homo sapiens (human)	0.0397
Delta-type opioid receptor	Homo sapiens (human)	0.1896
Kappa-type opioid receptor	Cavia porcellus (domestic guinea pig)	0.05
Kappa-type opioid receptor	Homo sapiens (human)	0.0795
Mu-type opioid receptor	Mus musculus (house mouse)	0.0154
Mu-type opioid receptor	Cavia porcellus (domestic guinea pig)	0.0089
Beta-2 adrenergic receptor	Cavia porcellus (domestic guinea pig)	0.0055

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bourin, M; Colombel, MC; Malinge, M; Vasar, E	1
Cong, B; Li, S; Ma, C; Meng, Y; Ni, Z; Wen, D; Yu, H	1

Other Studies

2 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and naloxone

Article	Year
Cholecystokinin receptor agonists block the jumping behaviour precipitated in morphine-dependent mice by naloxone. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9, Issue:1-2 Topics: Animals; Ceruletide; Devazepide; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Pyrazoles; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Tetragastrin; Thiorphan	1999
Effects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in rats. PloS one, 2012, Volume: 7, Issue:7 Topics: Animals; Conditioning, Psychological; Devazepide; Male; Morphine Dependence; Naloxone; Pyrazoles; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Spatial Behavior; Substance Withdrawal Syndrome	2012

Article

Year

Cholecystokinin receptor agonists block the jumping behaviour precipitated in morphine-dependent mice by naloxone.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9, Issue:1-2

Topics: Animals; Ceruletide; Devazepide; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Pyrazoles; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Tetragastrin; Thiorphan

1999

Effects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in rats.

PloS one, 2012, Volume: 7, Issue:7

Topics: Animals; Conditioning, Psychological; Devazepide; Male; Morphine Dependence; Naloxone; Pyrazoles; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Spatial Behavior; Substance Withdrawal Syndrome

2012